Wells Fargo & Company Kura Oncology, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 24,443 shares of KURA stock, worth $434,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,443

Previous 26,247 6.87%

Holding current value

$434,352

Previous $559,000 10.02%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$17.53 - $22.98 $31,624 - $41,455	-1,804 Reduced 6.87%	24,443 $503,000
Q1 2024 May 10, 2024	BUY	$13.42 - $23.53 $35,643 - $62,495	2,656 Added 11.26%	26,247 $559,000
Q4 2023 Feb 09, 2024	SELL	$7.58 - $14.38 $274,790 - $521,303	-36,252 Reduced 60.58%	23,591 $339,000
Q3 2023 Nov 13, 2023	BUY	$8.44 - $11.86 $11,697 - $16,437	1,386 Added 2.37%	59,843 $545,000
Q2 2023 Aug 15, 2023	SELL	$9.62 - $13.99 $145,973 - $212,284	-15,174 Reduced 20.61%	58,457 $618,000
Q1 2023 May 12, 2023	BUY	$10.71 - $14.6 $605,704 - $825,703	56,555 Added 331.2%	73,631 $900,000
Q4 2022 Feb 13, 2023	SELL	$11.23 - $16.9 $42,101 - $63,358	-3,749 Reduced 18.0%	17,076 $211,000
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $12,886 - $20,869	-1,073 Reduced 4.9%	20,825 $284,000
Q2 2022 Aug 12, 2022	SELL	$10.71 - $18.33 $70,386 - $120,464	-6,572 Reduced 23.08%	21,898 $402,000
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $225,386 - $324,878	-19,133 Reduced 40.19%	28,470 $458,000
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $110,346 - $176,717	9,030 Added 23.41%	47,603 $667,000
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $50,161 - $70,655	-3,253 Reduced 7.78%	38,573 $722,000
Q2 2021 Aug 16, 2021	SELL	$20.85 - $29.88 $1.34 Million - $1.92 Million	-64,367 Reduced 60.61%	41,826 $873,000
Q1 2021 May 13, 2021	SELL	$24.75 - $39.14 $1.6 Million - $2.54 Million	-64,779 Reduced 37.89%	106,193 $3 Million
Q4 2020 Feb 09, 2021	BUY	$29.0 - $41.62 $3.45 Million - $4.95 Million	118,836 Added 227.93%	170,972 $5.58 Million
Q3 2020 Nov 05, 2020	SELL	$16.3 - $30.64 $7,775 - $14,615	-477 Reduced 0.91%	52,136 $1.6 Million
Q2 2020 Aug 13, 2020	BUY	$7.95 - $18.81 $103,413 - $244,680	13,008 Added 32.84%	52,613 $858,000
Q1 2020 May 14, 2020	BUY	$6.45 - $14.04 $255,452 - $556,054	39,605 New	39,605 $394,000

Others Institutions Holding KURA

# of Institutions

184

Shares Held

79.6M

Call Options Held

148K

Put Options Held

63K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.19B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Kura Oncology, Inc. Transaction History